Yahoo Web Search

Search results

1. Top Stories

   • bovnews

     The Technical Story of Aurinia Pharmaceuticals Inc (AUPH) Stock

     Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. We previously noted in another research note published on May 05,

     3 days ago

   • The Valdosta Daily Times

     Aurinia Will Attend 2024 Jefferies Global Healthcare Conference

     Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will attend the 2024 Jefferies Global Healthcare Conference in New York from June 4-6, 2024.

     2 days ago

   • Yahoo Finance

     Shareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) have lost 64%, as stock drops 9.5% this past week

     But the last three years have been particularly tough on longer term Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) shareholders. Unfortunately, they have held through a 64% decline in the share price in that time. And the ride hasn't got any smoother in ...

     6 days ago

   • bovnews

     Trading Aurinia Pharmaceuticals Inc (AUPH) Stock is a good strategy

     Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. We previously noted in another research note published on May 05,

     2 weeks ago

   View all

2. www.auriniapharma.com › investors-and-media › newsPress Releases :: Aurinia Pharmaceuticals Inc. (AUPH)

   www.auriniapharma.com › investors-and-media › news

   • Cached

   May 7, 2024 · UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference April 15, 2024 • 6:00 am EDT Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024

3. www.auriniapharma.com › investors-and-media › newsNews & Events :: Aurinia Pharmaceuticals Inc. (AUPH)

   www.auriniapharma.com › investors-and-media › news

   • Cached

   May 9, 2024 • 6:00 am EDT. Aurinia Presents Data Reinforcing LUPKYNIS ® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024. Upcoming Events View All Events. Jun 14, 2024 • 12:00 pm EDT. 2024 Annual General Meeting. Latest Presentation View All Presentations. Aurinia 2024 Corporate Presentation.

4. finance.yahoo.com › news › aurinia-pharmaceuticalsAurinia Pharmaceuticals Reports Third Quarter and Nine Months ...

   finance.yahoo.com › news › aurinia-pharmaceuticals

   • Cached

   Nov 2, 2023 · ROCKVILLE, Md. & EDMONTON, Alberta, November 02, 2023 -- ( BUSINESS WIRE )--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for the...

5. finance.yahoo.com › quote › AUPHAurinia Pharmaceuticals Inc. (AUPH) Latest Stock News ...

   finance.yahoo.com › quote › AUPH

   • Cached

   Market Open. All. News. Press Releases. Shareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) have lost 64%, as stock drops 9.5% this past week. Investing in stocks inevitably means buying...

6. finance.yahoo.com › news › aurinia-discloses-2023Aurinia Discloses 2023 Year-End Financial and Operational ...

   finance.yahoo.com › news › aurinia-discloses-2023

   • Cached

   Feb 15, 2024 · ROCKVILLE, Maryland & EDMONTON, Alberta, February 15, 2024--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today provided an update on its 2023 fourth quarter and...

7. www.auriniapharma.com › investors-and-media › newsAurinia Pharmaceuticals Reports Third Quarter and Nine Months ...

   www.auriniapharma.com › investors-and-media › news

   • Cached

   Nov 2, 2023 · XBRL. ZIP. Net product revenue of $40.8 million for the third quarter of 2023; an increase of 60% over the prior year third quarter. Total net revenue of $130.4 million for the nine months ended September 30, 2023, an increase of 24% over prior year.

8. www.businesswire.com › news › homeAurinia Acquires Novel Pipeline Assets Targeting Autoimmune ...

   www.businesswire.com › news › home

   • Cached

   Aug 17, 2021 · VICTORIA, British Columbia-- ( BUSINESS WIRE )-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced the addition of two novel assets that will expand the...